NCT00995683

Brief Summary

The goal of this study is to evaluate the effect of preventive intravenous infusion of half molar sodium lactate on the onset of hypertensive intracranial episodes in severe head trauma. The investigators hypothesize that preventive intravenous administration of sodium lactate will decrease the number of treatments required to decrease intracranial pressure during 48 hours.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jun 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2009

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 15, 2009

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

July 12, 2011

Status Verified

May 1, 2011

Enrollment Period

1.9 years

First QC Date

October 10, 2009

Last Update Submit

July 9, 2011

Conditions

Keywords

intracranial hypertensionneurological outcomeosmotherapy

Outcome Measures

Primary Outcomes (1)

  • the number of treatments required for intracranial hypertensive episodes during the first 48 hours following ICU admission

    48 hours

Secondary Outcomes (1)

  • the neurological outcome at six months evaluated by the glasgow outcome scale

    6 months

Study Arms (2)

half sodium lactate

EXPERIMENTAL

infusion of 0.5 ml/kg/day during 48 hours

Drug: half molar sodium lactate

isotonic sodium chloride

ACTIVE COMPARATOR

infusion of 0.5 ml/kg during 48 hours

Drug: isotonic sodium chloride

Interventions

intravenous infusion of 0.5 ml/kg during 48 hours

Also known as: sodium lactate
half sodium lactate

intravenous infusion of 0.5 ml/kg during 48 hours

Also known as: sodium chloride
isotonic sodium chloride

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • severe head trauma with a glasgow coma scale less than 9

You may not qualify if:

  • prehospital cardiac arrest
  • severe hemorrhage shock
  • severe circulatory or respiratory failure
  • medullar trauma
  • prehospital osmotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut d'Anesthesiologie des Alpes maritimes

Nice, Nice, 06000, France

Location

Related Publications (1)

  • Ichai C, Armando G, Orban JC, Berthier F, Rami L, Samat-Long C, Grimaud D, Leverve X. Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med. 2009 Mar;35(3):471-9. doi: 10.1007/s00134-008-1283-5. Epub 2008 Sep 20.

MeSH Terms

Conditions

Craniocerebral TraumaIntracranial Hypertension

Interventions

Sodium LactateSodium Chloride

Condition Hierarchy (Ancestors)

Trauma, Nervous SystemNervous System DiseasesWounds and InjuriesBrain DiseasesCentral Nervous System Diseases

Intervention Hierarchy (Ancestors)

LactatesHydroxy AcidsCarboxylic AcidsOrganic ChemicalsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Carole Ichai, MD, PhD

    Institut d'Anesthesiologie des Alpes Maritimes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 10, 2009

First Posted

October 15, 2009

Study Start

June 1, 2009

Primary Completion

May 1, 2011

Study Completion

May 1, 2011

Last Updated

July 12, 2011

Record last verified: 2011-05

Locations